FindTrial
Sign In

Comparision Of Efficay And Adverse Effects Of Two Topicals In Treatment Of Localised Alopecia Areata - METHOTREXATE ONE PERCENTAGE GEL TOFACITINIB Versus TWO PERCENTAGE GEL

A Comparative Study On Efficacy And Adverse Effects Of METHOTREXATE ONE PERCENTAGE GEL Versus TOFACITINIB TWO PERCENTAGE GEL In The Treatment Of Localised Alopecia Areata - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/069460
Enrollment
104
Registered
2024-06-25
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L638- Other alopecia areata

Interventions

Intervention1: TOFACITINIB 2% GEL: Daily Once Local Application And Follow Up For Every 2 Weeks until 16 Weeks Intervention2: METHOTREXATE 1% GEL: Daily Once Local Application And Follow Up For Every

Sponsors

DR M Yashaswini
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of more than 18 Years. 2.Patients of both the genders. 3.Patients of localised alopecia over any part of the body.

Exclusion criteria

Exclusion criteria: 1.Patients with other systemic illness-Cardiac, Renal, Hepatic Illness. 2.Severely immunocompromised. 3.Pregnancy. 4.Patients who have undergone treatment recently with other modalities in Past 6 weeks. 5.PATIENT NOT GIVING CONSENT FOR THE STUDY

Design outcomes

Primary

MeasureTime frame
Trichoscopic Evaluation . Lesional Area Density (LAD) SCORE. Global Photographic Assessment (GPA) ScaleTimepoint: Baseline . Two weeks. Four weeks. Six weeks. Eight weeks . Ten weeks. Twelve weeks . Fourteen weeks. Sixteen weeks.—

Secondary

MeasureTime frame
Post treatment adverse effects & efficacy of TOFACITINIB 2% GEL & METHOTREXATE 1 % GELTimepoint: Follow up visit for every 2 weeks i.e, 2,4,6,8 till 8 weeks—

Countries

India

Contacts

Public ContactM Yashaswini

Sri Devaraj Urs Medical College

sk5787@gmail.com9535071967

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026